ELTX
Elicio Therapeutics Inc

370
Loading...
Loading...
News
all
press releases
Why Is Cancer Vaccine Developer Elicio Therapeutics Stock Trading Lower On Friday?
Elicio Therapeutics announced promising preliminary data from the AMPLIFY-7P Phase 1a study of ELI-002 7P, showing extended median disease-free survival in patients with mKRAS-driven solid...
Benzinga·1y ago
News Placeholder
More News
News Placeholder
Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting
68% of patients treated with ELI-002 developed cytotoxic mKRAS-specific CD4+ T cells84% of patients treated with ELI-002 developed cytotoxic mKRAS-specific CD8+ T cellsThe majority of ELI-002-treated...
Globe Newswire·1y ago
News Placeholder
ELTX Stock Earnings: Elicio Therapeutics Misses EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ELTX stock results show that Elicio Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. The post...
InvestorPlace·1y ago
News Placeholder
Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates
ELI-002 2P clinical immunogenicity data were accepted for a poster presentation at the AACR Annual Meeting 2024ELI-007 and ELI-008 preclinical data were accepted for a poster presentation at the AACR...
Globe Newswire·1y ago
News Placeholder
Elicio Therapeutics GAAP EPS of -$6.96
Elicio Therapeutics GAAP EPS of -$6.96...
SeekingAlpha.com: All News·1y ago
News Placeholder
Elicio Therapeutics to sell 1.03M shares $5.81 in private placement financing
Elicio Therapeutics to sell 1.03M shares $5.81 in private placement financing...
SeekingAlpha.com: All News·1y ago
News Placeholder
Elicio Therapeutics to sell 1.03M shares $5.81 in private placement financing
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Elicio Therapeutics Announces $6.0 Million Private Placement Financing
BOSTON, March 18, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, Elicio Therapeutics or Elicio ), a clinical-stage biotechnology company developing a pipeline of novel...
Globe Newswire·1y ago
News Placeholder
Elicio Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
BOSTON, March 06, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, Elicio Therapeutics or Elicio ), a clinical-stage biotechnology company developing a pipeline of novel...
Globe Newswire·2y ago
News Placeholder
Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
BOSTON, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, Elicio Therapeutics or Elicio ), a clinical-stage biotechnology company developing a pipeline of novel...
Globe Newswire·2y ago

Latest ELTX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.